BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36231079)

  • 1. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
    Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
    Bernardo BC; Gao XM; Tham YK; Kiriazis H; Winbanks CE; Ooi JY; Boey EJ; Obad S; Kauppinen S; Gregorevic P; Du XJ; Lin RC; McMullen JR
    PLoS One; 2014; 9(2):e90337. PubMed ID: 24587330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1.
    Zhang XL; Zhang G; Bai ZH
    Cell Biol Int; 2021 Mar; 45(3):642-653. PubMed ID: 33289184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.
    Huang JP; Chang CC; Kuo CY; Huang KJ; Sokal EM; Chen KH; Hung LM
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
    Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
    Bernardo BC; Nguyen SS; Winbanks CE; Gao XM; Boey EJ; Tham YK; Kiriazis H; Ooi JY; Porrello ER; Igoor S; Thomas CJ; Gregorevic P; Lin RC; Du XJ; McMullen JR
    FASEB J; 2014 Dec; 28(12):5097-110. PubMed ID: 25145628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of MicroRNA-34a in Anti-Apoptotic Effects of Granulocyte-Colony Stimulating Factor in Diabetic Cardiomyopathy.
    Park IH; Song YS; Joo HW; Shen GY; Seong JH; Shin NK; Cho YJ; Lee Y; Shin JH; Lim YH; Kim H; Kim KS
    Diabetes Metab J; 2020 Feb; 44(1):173-185. PubMed ID: 31237127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
    Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
    Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
    Bernardo BC; Nguyen SS; Gao XM; Tham YK; Ooi JY; Patterson NL; Kiriazis H; Su Y; Thomas CJ; Lin RC; Du XJ; McMullen JR
    Sci Rep; 2016 Mar; 6():22442. PubMed ID: 26928825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
    Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
    J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells.
    Xue M; Li Y; Hu F; Jia YJ; Zheng ZJ; Wang L; Xue YM
    Biochem Biophys Res Commun; 2018 Mar; 498(1):38-44. PubMed ID: 29371016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes.
    Li Y; Ma J; Zhu H; Singh M; Hill D; Greer PA; Arnold JM; Abel ED; Peng T
    Diabetes; 2011 Nov; 60(11):2985-94. PubMed ID: 21911754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
    Costantino S; Paneni F; Lüscher TF; Cosentino F
    Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.